A clinical trial of dextromethorphan in amyotrophic lateral sclerosis

Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ole Gredal, Lene Werdelin, S. Bąk, Peter Brøgger Christensen, Gudrun Boysen, Michael Kristensen, Jesper Jespersen, Lisbeth Regeur, H H Hinge, Troels S. Jensen
Formato: Artigo
Lenguaje:inglés
Publicado: 2009
Acceso en línea:https://doi.org/10.1111/j.1600-0404.1997.tb00231.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!